Back to Search Start Over

Liraglutide Injection (Saxenda®).

Authors :
Elliott, William T.
Chan, James
Source :
Internal Medicine Alert. 6/15/2015, Vol. 37 Issue 11, p84-85. 2p.
Publication Year :
2015

Abstract

The article offers information on liraglutide, a glucagon-like peptide 1 receptor antagonist, traded as Saxenda by Novo Nordisk, which can be used for weight management in adults, citing its disadvantages like effects in patients with medullary thyroid carcinoma and its clinical implications.

Subjects

Subjects :
*TYPE 2 diabetes
*OBESITY
*COST analysis
*GLUCAGON-like peptide-1 agonists
*THERAPEUTICS

Details

Language :
English
ISSN :
0195315X
Volume :
37
Issue :
11
Database :
Academic Search Index
Journal :
Internal Medicine Alert
Publication Type :
Periodical
Accession number :
103252046

Tools

Authors Abstract Subjects Details